{"id":11874,"date":"2026-03-31T16:52:33","date_gmt":"2026-03-31T14:52:33","guid":{"rendered":"https:\/\/crcm-marseille.fr\/uncategorized\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/"},"modified":"2026-04-02T19:34:06","modified_gmt":"2026-04-02T17:34:06","slug":"31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research","status":"publish","type":"post","link":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/","title":{"rendered":"31 PhD positions available at CRCM: discover research opportunities in cancer research"},"content":{"rendered":"\n<p>The Marseille Cancer Research Center (CRCM) is launching its doctoral recruitment campaign with <strong>31 PhD projects<\/strong> led by its research teams. These projects cover a broad spectrum of cancer research, ranging from fundamental biology to translational approaches. <\/p>\n\n\n\n<p>Immunotherapy, tumor microenvironment, leukemias, solid tumors, epigenetics, and treatment resistance: this diversity reflects the scientific dynamism of CRCM.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>How to apply ?<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>These projects are offered within the doctoral schools<strong> <a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/\">ED658<\/a> <\/strong>and <a href=\"https:\/\/ecole-doctorale-659.univ-amu.fr\/\" type=\"link\" id=\"https:\/\/ecole-doctorale-659.univ-amu.fr\/\">ED659<\/a>.<\/li>\n\n\n\n<li>Applicants must apply through the competitive selection process of the relevant doctoral schools. <\/li>\n\n\n\n<li>Prospective candidates are strongly encouraged to contact supervisors prior to applying.<\/li>\n\n\n\n<li>Application deadline: May 11<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>PhD projects<\/strong><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP38_CHAMES%20ANTONOFF_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP38_CHAMES%20ANTONOFF_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">1. Exploring bispecific molecular tools to optimize car-t cell therapy in oncology<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/en\/ohio-department\/antibody-therapeutics-and-immunotargeting\/\">Anticorps Th\u00e9rapeutiques et Immunociblage<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"octavia.antonoff@univ-amu.fr\" type=\"link\" id=\"octavia.antonoff@univ-amu.fr\">Octavia Antonoff<\/a> , <a href=\"remi.lasserre@inserm.fr\">R\u00e9mi Lasserre<\/a>, <a href=\"patrick.chames@inserm.fr\">Patrick Chames<\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Development of tools to better control CAR-T cell activity in order to reduce toxicity while maintaining their antitumor efficacy.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71658&amp;labos=\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71658&amp;labos=\" target=\"_blank\" rel=\"noreferrer noopener\">2. Role of Leukemic Stem Cell and bone marrow niche heterogeneity in drug resistance<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/team\/michel-aurrand-lions\/departement-ohio\/equipe-interactions-leuco-stromales-dans-lhematopoiese-normale-et-pathologique-departement-ohio\/\">Interactions Leuco\/Stromales dans l\u2019h\u00e9matopo\u00ef\u00e8se normale et pathologique<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><strong><a href=\"michel.aurrand-lions@inserm.fr\" type=\"link\" id=\"michel.aurrand-lions@inserm.fr\">Michel Aurrand-Lions<\/a> <\/strong><\/mark><br><strong>Summary :<\/strong> Study of the interactions between leukemic cells and the bone marrow microenvironment to understand mechanisms of treatment resistance.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP94_FAURIAT_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP94_FAURIAT_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">3. Study of alterations of normal residual haematopoiesis and immune cells in early-stage leukaemia<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"> <a href=\"https:\/\/crcm-marseille.fr\/team\/michel-aurrand-lions\/departement-ohio\/equipe-interactions-leuco-stromales-dans-lhematopoiese-normale-et-pathologique-departement-ohio\/\">Interactions Leuco\/Stromales dans l\u2019h\u00e9matopo\u00ef\u00e8se normale et pathologique<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"cyril.fauriat@inserm.fr\">Cyril Fauriat<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Identification of early hematopoietic alterations and their role in leukemia initiation.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">4. Preclinical Development of Chimeric Antigen Receptors (CAR) against the Receptor PTK7<\/h3>\n\n\n\n<p><strong>Team :<\/strong> <mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><strong><a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/targeting-signaling-networks-and-the-microenvironment-in-cancer\/\">Ciblage des r\u00e9seaux de signalisation et du microenvironnement dans le cancer<\/a> <\/strong><\/mark><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"jean-paul.borg@inserm.fr\">Jean-Paul Borg<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Development of novel CAR-T approaches to effectively target solid tumors and overcome tumor escape mechanisms.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71862&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">5. Identification of evolutive liver preneoplastic drivers as candidates for preventive screenings and targeted therapy<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/targeting-signaling-networks-and-the-microenvironment-in-cancer\/\">Ciblage des r\u00e9seaux de signalisation et du microenvironnement dans le cancer<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"celia.sequera-hurtado@univ-amu.fr\">C\u00e9lia Sequera<\/a>, <a href=\"avais.daulat@inserm.fr\" type=\"link\" id=\"avais.daulat@inserm.fr\">Avais Daulat <\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Study of the early stages of liver cancer development to identify biomarkers and therapeutic targets.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP90_Lamballe_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP90_Lamballe_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">6. Deciphering Tumor and Myeloid Cell Crosstalk during Immune Remodeling in Triple-Negative Breast Cancer<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/targeting-signaling-networks-and-the-microenvironment-in-cancer\/\">Ciblage des r\u00e9seaux de signalisation et du microenvironnement dans le cancer<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"fabienne.lamballe@univ-amu.fr\">Fabienne Lamballe<\/a>, <a href=\"paula.michea-veloso@univ-amu.fr\">Paula Michea-Veloso<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Analysis of interactions between tumor cells and immune cells to better understand tumor aggressiveness.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71653&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71653&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">7. COMPLICITY : COMPutationaL tools for NanoBooster In Cancer ImmunoTherapY<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/departement-translate-it\/equipe-compo-pharmacologie-computationnelle-et-oncologie-clinique-departement-translate-it\/\">COMPO : Pharmacologie COMPutationnelle et Oncologie clinique<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"joseph.ciccolini@inserm.fr\">Joseph Ciccolini<\/a>, <a href=\"anne.rodallec@univ-amu.fr\">Anne Rodallec <\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Development of immunomodulatory nanoparticles to enhance the efficacy of immunotherapies.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP59_Guillaumond_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP59_Guillaumond_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">8. Metabolic chronotherapy: targeting cholesterol metabolism at a specific time-of-the-day to improve the treatment against pancreatic ductal adenocarcinoma<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/tumor-stromal-cell-crosstalk-and-metabolic-reprogramming-in-pancreatic-cancer\/\"><strong>Dialogue cellules stromales\/tumorales et reprogrammation m\u00e9tabolique dans les cancers du pancr\u00e9as<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"fabienne.guillaumond@inserm.fr\">Fabienne Guillaumond<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Study of the role of circadian rhythms in tumor metabolism to optimize treatment administration.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70475&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70475&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">9. Role of Interferon-\u03b3 in Inducing an Epigenetic Cancer Fate During Breast Tumor Initiation<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/comet-department\/equipe-cellules-souches-epitheliales-et-cancer-departement-comet\/\">Cellules souches \u00e9pith\u00e9liales et cancer<\/a> <\/mark><\/strong><br><strong>Contact :<\/strong> <a href=\"christophe.ginestier@inserm.fr\"><strong>Christophe Ginestier <\/strong><\/a><br><strong>Summary :<\/strong> Analysis of the role of inflammation and epigenetic mechanisms in the initiation of breast cancer.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP107_Llorente_2026_Microbio_CRCM%20%282%29.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">10. Study of the mechanisms ensuring meiotic recombination between sex chromosomes in mice<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/genome-integrity-department\/genome-dynamics-and-recombination\/\"><strong>Dynamique du G\u00e9nome et Recombinaison<\/strong><\/a><br><strong>Contact :<\/strong> <a href=\"laurent.acquaviva@inserm.fr\"><strong>Laurent Acquaviva<\/strong><\/a>, <a href=\"bertrand.llorente@inserm.fr\" type=\"link\" id=\"bertrand.llorente@inserm.fr\"><strong>Bertrand Llorente<\/strong><\/a><br><strong>Summary :<\/strong> Study of proteins involved in the recombination of sex chromosomes during meiosis.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP14_Geoffrey%20Guittard_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP14_Geoffrey%20Guittard_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>11. In vivo expression of a chimeric antigen receptor (CAR), CAR-Nectin-4, in cytotoxic cells and modulation of CISH, an immune checkpoint, to enhance the anti-tumor response<\/strong><\/a><\/h3>\n\n\n\n<p><strong>Team :<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"> <a href=\"https:\/\/crcm-marseille.fr\/ohio-department\/equipe-immunite-et-cancer-departement-ohio\/\">Immunit\u00e9 et Cancer<\/a><\/mark><\/strong><br><strong>Contact :<\/strong> <a href=\"geoffrey.guittard@inserm.fr\"><strong>Geoffrey Guittard <\/strong><\/a><br><strong>Summary :<\/strong> Development of immune engineering strategies to enhance the antitumor response.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70607&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70607&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">12. Reprogramming Tumor Stress to Overcome Immunosuppression and Sensitize PDAC to Immunotherapy<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team : <a href=\"https:\/\/crcm-marseille.fr\/ohio-department\/equipe-immunite-et-cancer-departement-ohio\/\">Immunit\u00e9 et Cancer<\/a><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"patricia.santofimia@inserm.fr\">Patricia Santofimia<\/a>, <a href=\"alice.carrier@inserm.fr\">Alice Carrier <\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Study of cellular stress mechanisms and their role in tumor immune evasion.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71395&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71395&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">13. Towards the discovery of new therapeutic targets in T-cell acute lymphoblastic leukemia<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/ohio-department\/integrative-molecular-biology-in-hematopoiesis-and-leukemia\/\"><strong>Biologie mol\u00e9culaire int\u00e9grative dans l\u2019h\u00e9matopo\u00ef\u00e8se et la leuc\u00e9mie<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"marie.loosveld@ap-hm.fr\">Marie Loosveld<\/a><\/mark><\/strong>, <a href=\"delphine.potier@cnrs.fr\" type=\"link\" id=\"delphine.potier@cnrs.fr\"><strong>Delphine Potier<\/strong><\/a><br><strong>Summary :<\/strong> Identification of novel targets for the development of immunotherapies in T-cell acute lymphoblastic leukemia.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71425&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71425&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">14. Epigenetic and transcriptomic profiling to understand treatment resistance in acute myeloid leukemia<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/ohio-department\/integrative-molecular-biology-in-hematopoiesis-and-leukemia\/\"><strong>Biologie mol\u00e9culaire int\u00e9grative dans l\u2019h\u00e9matopo\u00ef\u00e8se et la leuc\u00e9mie<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"estelle.duprez@inserm.fr\">Estelle Duprez<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Study of epigenetic mechanisms involved in treatment resistance.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP56_PayetBornet_2026_Biocel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP56_PayetBornet_2026_Biocel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">15. Deciphering clonal heterogeneity in Mixed Phenotype Acute Leukemias<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"> <a href=\"https:\/\/crcm-marseille.fr\/en\/ohio-department\/integrative-molecular-biology-in-hematopoiesis-and-leukemia\/\">Biologie mol\u00e9culaire int\u00e9grative dans l\u2019h\u00e9matopo\u00ef\u00e8se et la leuc\u00e9mie<\/a><\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"dominique.payet-bornet@inserm.fr\">Dominique Payet Bornet<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Analysis of the evolutionary trajectories of leukemic cells at the single-cell level.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP37_Poplineau_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP37_Poplineau_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">16. Epigenetic regulation of hematopoietic stem cell function in aging<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/ohio-department\/integrative-molecular-biology-in-hematopoiesis-and-leukemia\/\"><strong>Biologie mol\u00e9culaire int\u00e9grative dans l\u2019h\u00e9matopo\u00ef\u00e8se et la leuc\u00e9mie<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"mathilde.poplineau@inserm.fr\">Mathilde Poplineau<\/a>, <a href=\"chiara.taroni@inserm.fr\">Chiara Taroni<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Study of epigenetic changes associated with aging and immunity.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP43_GARCIN_2026_MicroBio_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP43_GARCIN_2026_MicroBio_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">17. Structural characterization of thrombospondin-1 (TSP1) and its interaction with CD47: toward the discovery of modulators of the CD47\u2013TSP1 complex through high-throughput screening<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/ohio-department\/equipe-biologie-structurale-et-chimie-biologie-integree-departement-ohio\/\"><strong>Biologie Structurale et Chimie-Biologie Int\u00e9gr\u00e9e<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"sarah.barelier@inserm.fr\">Sarah Barelier<\/a><\/mark><\/strong>, <a href=\"elsa.garcin@univ-amu.fr\" type=\"link\" id=\"elsa.garcin@univ-amu.fr\"><strong>Elsa Garcin<\/strong><\/a><br><strong>Summary :<\/strong> Developing new therapeutic strategies aimed at modulating immune interactions.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71843&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">18. Dissecting and targeting extracellular vesicle-mediated communication in TP53-mutated acute myeloid leukemia<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/departement-genome-integrity\/equipe-lesions-de-ladn-par-pontage-inter-brin-et-maladies-du-sang-departement-genome-integrity\/\"><strong>Dommages de l\u2019ADN et pathologies sanguines<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"raphael.leblanc@inserm.fr\">Raphael Leblanc<\/a> <\/mark>, <\/strong><a href=\"christophe.lachaud@inserm.fr\"><strong>Christophe Lachaud<\/strong><\/a><br><strong>Summary :<\/strong> Study of the role of extracellular vesicles in leukemia progression and resistance.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71739&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">19. Deciphering the role of N-acetylgalactosaminyltransferases 4, 6 and 12 in pancreatic adenocarcinoma aggressiveness and chemoresistance<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/translational-and-therapeutic-research-in-pancreatic-cancer\/\"><strong>Recherche Translationnelle et Th\u00e9rapeutique dans le Cancer du Pancr\u00e9as<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"eric.mas@inserm.fr\">Eric Mas<\/a> <\/mark><\/strong><br><strong>Summary : Identifying glycosylated biomarkers associated with tumor aggressiveness.<br><\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP85_SOUBEYRAN_2026_BioCel_CRCM_0.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP85_SOUBEYRAN_2026_BioCel_CRCM_0.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">20. PSMD2 ubiquitination as a theranostic marker and molecular target to predict and prevent resistance in pancreatic adenocarcinoma<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/translational-and-therapeutic-research-in-pancreatic-cancer\/\"><strong>Recherche Translationnelle et Th\u00e9rapeutique dans le Cancer du Pancr\u00e9as<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"philippe.soubeyran@inserm.fr\">Philippe Soubeyran<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Investigating mechanisms of chemotherapy resistance in pancreatic cancer.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71359&amp;labos=#version\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP35_Mamessier_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">21. Precision medicine strategies to target the Proliferative K2 Subtype in Colorectal Cancer Liver Metastases<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/predictive-oncology\/\">Oncologie Pr\u00e9dictive<\/a><\/mark><\/strong><br><strong>Contact :<\/strong> <a href=\"david.birnbaum@ap-hm.fr\"><strong>David Birnbaum<\/strong><\/a><br><strong>Summary :<\/strong> Identification of new therapeutic strategies targeting specific tumor subtypes.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP35_Mamessier_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">22. Dynamic characterization of survival programs in persistent tumor cells exposed to peri-operative chemotherapy in metastatic colorectal cancer<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/predictive-oncology\/\"><strong>Oncologie Pr\u00e9dictive<\/strong><\/a><br><strong>Contact :<\/strong> <a href=\"emilie.mamessier@inserm.fr\"><strong>Emilie Mamessier<\/strong><\/a><br><strong>Summary :<\/strong> Investigating treatment-resistant cells that drive disease relapse.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71706&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71706&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">23. Predicting the response to neoadjuvant therapies for operable aggressive breast cancers using a simple blood test: a new step toward real-time precision medicine<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/predictive-oncology\/\"><strong>Oncologie Pr\u00e9dictive<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"SABATIERR@ipc.unicancer.fr\">Renaud Sabatier<\/a>, <a href=\"emilie.denicolai@inserm.fr\">Emilie Denicolai<\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Development of blood-based tests to predict treatment response.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP63_Laureti_2026_Microbio_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP63_Laureti_2026_Microbio_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">24. How restarted replication in the presence of unrepaired lesions results in genome instability<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"https:\/\/crcm-marseille.fr\/en\/genome-integrity-department\/dna-damage-and-genome-instability\/\">Dommages de l\u2019ADN et instabilit\u00e9 du g\u00e9nome<\/a> ; <br><a href=\"https:\/\/crcm-marseille.fr\/en\/genome-integrity-department\/telomeres-and-chromatin\/\">T\u00e9lom\u00e8res et Chromatine<\/a><\/mark><\/strong><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"luisa.laureti@cnrs.fr\">Luisa Laureti,<\/a> <a href=\"karel.naiman@inserm.fr\">Karel Naiman<\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Investigating DNA replication mechanisms and their contribution to genomic instability.<\/p>\n\n\n\n<p><strong><a href=\"https:\/\/crcm-marseille.fr\/en\/phd-en\/phd-project-proposal-for-the-doctoral-school-call-2026\/\">To know more<\/a><\/strong><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP71_Gaillard_2026_Microbio_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP71_Gaillard_2026_Microbio_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">25. Interdependence of SLX4, RTEL1 and XPF in the handling of replication stress<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/genome-integrity-department\/structure-specific-endonuclease-control-and-genome-stability\/\"><strong>Contr\u00f4le des Endonucl\u00e9ases \u00e0 Sp\u00e9cificit\u00e9 de Structure et Stabilit\u00e9 du G\u00e9nome<\/strong><\/a><br><strong>Contact :<\/strong> <a href=\"stephanie.gon@inserm.fr\"><strong>St\u00e9phanie Gon<\/strong><\/a>, <a href=\"pierre-henri.gaillard@inserm.fr\"><strong>Pierre-henri Gaillard<\/strong><\/a><br><strong>Summary :<\/strong> Analysis of replication stress response mechanisms in cancer cells.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?labos=&amp;langue=fr&amp;matricule_prop=71637&amp;site=ed659#version\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP71_Gaillard_2026_Microbio_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">26. Structural and functional consequences of the R481Q disease-causing mutation affecting the Fanconi pathway factor SLX4\/FANCP<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/genome-integrity-department\/structure-specific-endonuclease-control-and-genome-stability\/\"><strong>Contr\u00f4le des Endonucl\u00e9ases \u00e0 Sp\u00e9cificit\u00e9 de Structure et Stabilit\u00e9 du G\u00e9nome<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"agnes.tissier@inserm.fr\">Agn\u00e8s Tissier<\/a>, <a href=\"pierre-henri.gaillard@inserm.fr\">Pierre-henri Gaillard <\/a><\/mark><\/strong><br><strong>Summary :<\/strong> Study of the consequences of a mutation affecting genomic stability.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70458&amp;labos=\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70458&amp;labos=\" target=\"_blank\" rel=\"noreferrer noopener\">27. Overcoming radio- and chemo-resistance in pediatric high-grade glioma<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/reverse-molecular-pharmacology-in-pediatric-oncology-remap-4-kids\/\"><strong>Pharmacologie Mol\u00e9culaire invers\u00e9e en oncologie p\u00e9diatrique (REMAP-4kids)<\/strong><\/a><br><strong>Contact :<\/strong> <a href=\"eddy.pasquier@inserm.fr\"><strong>Eddy Pasquier <\/strong><\/a><br><strong>Summary :<\/strong> Identification of effective therapeutic combinations for pediatric brain tumors.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP75_LEGRAND_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP75_LEGRAND_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">28. Targeting iron metabolism to overcome therapeutic resistance in refractory pediatric cancer<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/translate-it-department\/reverse-molecular-pharmacology-in-pediatric-oncology-remap-4-kids\/\"><strong>Pharmacologie Mol\u00e9culaire invers\u00e9e en oncologie p\u00e9diatrique (REMAP-4kids)<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"marion.le-grand@inserm.fr\">Marion Le Grand<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Exploration of the role of iron metabolism in treatment resistance.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70009&amp;labos=#version\" type=\"link\" id=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=70009&amp;labos=#version\" target=\"_blank\" rel=\"noreferrer noopener\">29. Role of the Replication Protein A (RPA) in telomere maintenance : from molecular mechanism to telomere diseases<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/genome-integrity-department\/telomeres-and-chromatin\/\"><strong>T\u00e9lom\u00e8res et Chromatine<\/strong><\/a><br><strong>Contact :<\/strong> <strong><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"><a href=\"stephane.coulon@inserm.fr\">St\u00e9phane Coulon<\/a> <\/mark><\/strong><br><strong>Summary :<\/strong> Study of telomere stability mechanisms and associated diseases.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/adum.fr\/as\/ed\/voirproposition.pl?langue=fr&amp;site=ed659&amp;matricule_prop=71825&amp;labos=\" target=\"_blank\" rel=\"noreferrer noopener\">30. Exploring strategies to improve the efficacy of antibody-drug conjugates in breast cancer treatment<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/extracellular-vesicles-from-signalling-mechanistics-to-therapeutic-engineering\/\"><strong>V\u00e9sicules extracellulaires : m\u00e9canismes de signalisation et ing\u00e9nierie th\u00e9rapeutique<\/strong><\/a><br><strong>Contact :<\/strong> <a href=\"rania.ghossoub@inserm.fr\"><strong>Rania Ghossoub <\/strong><\/a>,<a href=\"https:\/\/crcm-marseille.fr\/team\/pascale-zimmermann\/\"> <strong>Pascale Zimmermann<\/strong><\/a><br><strong>Summary :<\/strong> Understanding the mechanisms of resistance to targeted therapies.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><a href=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP51_Thuault_2026_BioCel_CRCM.pdf\" type=\"link\" id=\"https:\/\/ecole-doctorale-658.univ-amu.fr\/system\/files\/media-ressource\/PP51_Thuault_2026_BioCel_CRCM.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">31. Role of syntenin-dependent extracellular vesicles in cancer stemness<\/a><\/strong><\/h3>\n\n\n\n<p><strong>Team :<\/strong> <a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/extracellular-vesicles-from-signalling-mechanistics-to-therapeutic-engineering\/\"><strong><a href=\"https:\/\/crcm-marseille.fr\/en\/comet-department\/extracellular-vesicles-from-signalling-mechanistics-to-therapeutic-engineering\/\"><strong>V\u00e9sicules extracellulaires : m\u00e9canismes de signalisation et ing\u00e9nierie th\u00e9rapeutique<\/strong><\/a><\/strong><\/a><br\/><strong>Contact :<mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\"> <a href=\"sylvie.thuault@inserm.fr\">Sylvie Thuault <\/a><\/mark><\/strong><br\/><strong>Summary :<\/strong> Study of the role of extracellular vesicles in tumor plasticity.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CRCM offers 31 PhD projects covering a wide range of topics in cancer research. These projects are proposed within the doctoral schools ED658 and ED659 and are accessible through their competitive selection process. <\/p>\n","protected":false},"author":2,"featured_media":11836,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_tec_requires_first_save":true,"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","footnotes":""},"categories":[196,226,197,231,198,232,199,304,200,201,202,204,205,206,207,209,210,214,194,223,195,225],"tags":[],"class_list":["post-11874","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-benzekry-ciccolini-team","category-team-lachaud","category-team-dusetti-iovanna","category-team-vasseur-tomasini","category-ohio-department","category-team-zimmermann","category-team-aurand-lions","category-team-collette-morelli","category-genome-integrity-department","category-gaillard-team","category-team-chames","category-comet-department","category-crcm-articles","category-team-charafe-ginestier","category-the-coulon-team","category-bertucci-mamessier-team","category-team-pasquier-andre","category-team-borg-maina","category-phd-en","category-pages-team","category-translate-it-department","category-duprez-team"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>31 PhD positions available at CRCM: discover research opportunities in cancer research | CRCM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"31 PhD positions available at CRCM: discover research opportunities in cancer research | CRCM\" \/>\n<meta property=\"og:description\" content=\"CRCM offers 31 PhD projects covering a wide range of topics in cancer research. These projects are proposed within the doctoral schools ED658 and ED659 and are accessible through their competitive selection process.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\" \/>\n<meta property=\"og:site_name\" content=\"CRCM\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-31T14:52:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T17:34:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"333\" \/>\n\t<meta property=\"og:image:height\" content=\"198\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Delphine\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Delphine\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\"},\"author\":{\"name\":\"Delphine\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/c64f443de57a1232a094bf8b46a2e8cb\"},\"headline\":\"31 PhD positions available at CRCM: discover research opportunities in cancer research\",\"datePublished\":\"2026-03-31T14:52:33+00:00\",\"dateModified\":\"2026-04-02T17:34:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\"},\"wordCount\":1360,\"publisher\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp\",\"articleSection\":[\"Benzekry \/ Ciccolini team\",\"Lachaud team\",\"Dusetti \/ Iovanna team\",\"Vasseur \/ Tomasini team\",\"OHIO Department\",\"Zimmermann team\",\"Aurand-Lions team\",\"Collette \/ Morelli team\",\"Genome Integrity Department\",\"Gaillard team\",\"Chames team\",\"Comet Department\",\"CRCM articles\",\"Charafe \/ Ginestier team\",\"Coulon team\",\"Bertucci \/ Mamessier team\",\"Pasquier \/ Andr\u00e9 team\",\"Borg \/ Maina team\",\"PhD\",\"Pag\u00e8s team\",\"Translate-it Department\",\"Duprez team\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\",\"name\":\"31 PhD positions available at CRCM: discover research opportunities in cancer research | CRCM\",\"isPartOf\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp\",\"datePublished\":\"2026-03-31T14:52:33+00:00\",\"dateModified\":\"2026-04-02T17:34:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage\",\"url\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp\",\"contentUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp\",\"width\":333,\"height\":198},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/crcm-marseille.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"31 PhD positions available at CRCM: discover research opportunities in cancer research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#website\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/\",\"name\":\"CRCM\",\"description\":\"Marseille Cancer Research Center\",\"publisher\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\"},\"alternateName\":\"Centre de recherche en canc\u00e9rologie de Marseille\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/crcm-marseille.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#organization\",\"name\":\"CRCM\",\"alternateName\":\"Centre de Recherche en Canc\u00e9rologie de Marseille\",\"url\":\"https:\/\/crcm-marseille.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png\",\"contentUrl\":\"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png\",\"width\":11811,\"height\":7171,\"caption\":\"CRCM\"},\"image\":{\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.youtube.com\/@CRCM-marseille\",\"https:\/\/www.linkedin.com\/company\/crcm-marseille\/\",\"https:\/\/bsky.app\/profile\/crcm.bsky.social\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/c64f443de57a1232a094bf8b46a2e8cb\",\"name\":\"Delphine\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9bac40359a047dfd71cc05baef7c1bb9cd40093de92cc1527c35a1a818c1a3fd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9bac40359a047dfd71cc05baef7c1bb9cd40093de92cc1527c35a1a818c1a3fd?s=96&d=mm&r=g\",\"caption\":\"Delphine\"},\"url\":\"https:\/\/crcm-marseille.fr\/en\/author\/contactbioself-communication-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"31 PhD positions available at CRCM: discover research opportunities in cancer research | CRCM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/","og_locale":"en_US","og_type":"article","og_title":"31 PhD positions available at CRCM: discover research opportunities in cancer research | CRCM","og_description":"CRCM offers 31 PhD projects covering a wide range of topics in cancer research. These projects are proposed within the doctoral schools ED658 and ED659 and are accessible through their competitive selection process.","og_url":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/","og_site_name":"CRCM","article_published_time":"2026-03-31T14:52:33+00:00","article_modified_time":"2026-04-02T17:34:06+00:00","og_image":[{"width":333,"height":198,"url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp","type":"image\/webp"}],"author":"Delphine","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Delphine","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#article","isPartOf":{"@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/"},"author":{"name":"Delphine","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/c64f443de57a1232a094bf8b46a2e8cb"},"headline":"31 PhD positions available at CRCM: discover research opportunities in cancer research","datePublished":"2026-03-31T14:52:33+00:00","dateModified":"2026-04-02T17:34:06+00:00","mainEntityOfPage":{"@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/"},"wordCount":1360,"publisher":{"@id":"https:\/\/crcm-marseille.fr\/en\/#organization"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage"},"thumbnailUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp","articleSection":["Benzekry \/ Ciccolini team","Lachaud team","Dusetti \/ Iovanna team","Vasseur \/ Tomasini team","OHIO Department","Zimmermann team","Aurand-Lions team","Collette \/ Morelli team","Genome Integrity Department","Gaillard team","Chames team","Comet Department","CRCM articles","Charafe \/ Ginestier team","Coulon team","Bertucci \/ Mamessier team","Pasquier \/ Andr\u00e9 team","Borg \/ Maina team","PhD","Pag\u00e8s team","Translate-it Department","Duprez team"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/","url":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/","name":"31 PhD positions available at CRCM: discover research opportunities in cancer research | CRCM","isPartOf":{"@id":"https:\/\/crcm-marseille.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage"},"thumbnailUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp","datePublished":"2026-03-31T14:52:33+00:00","dateModified":"2026-04-02T17:34:06+00:00","breadcrumb":{"@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#primaryimage","url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp","contentUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2026\/03\/PhD-CRCM.webp","width":333,"height":198},{"@type":"BreadcrumbList","@id":"https:\/\/crcm-marseille.fr\/en\/phd-en\/31-phd-positions-available-at-crcm-discover-research-opportunities-in-cancer-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/crcm-marseille.fr\/en\/"},{"@type":"ListItem","position":2,"name":"31 PhD positions available at CRCM: discover research opportunities in cancer research"}]},{"@type":"WebSite","@id":"https:\/\/crcm-marseille.fr\/en\/#website","url":"https:\/\/crcm-marseille.fr\/en\/","name":"CRCM","description":"Marseille Cancer Research Center","publisher":{"@id":"https:\/\/crcm-marseille.fr\/en\/#organization"},"alternateName":"Centre de recherche en canc\u00e9rologie de Marseille","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/crcm-marseille.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/crcm-marseille.fr\/en\/#organization","name":"CRCM","alternateName":"Centre de Recherche en Canc\u00e9rologie de Marseille","url":"https:\/\/crcm-marseille.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png","contentUrl":"https:\/\/crcm-marseille.fr\/wp-content\/uploads\/2024\/10\/logo-crcm.png","width":11811,"height":7171,"caption":"CRCM"},"image":{"@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/@CRCM-marseille","https:\/\/www.linkedin.com\/company\/crcm-marseille\/","https:\/\/bsky.app\/profile\/crcm.bsky.social"]},{"@type":"Person","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/c64f443de57a1232a094bf8b46a2e8cb","name":"Delphine","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/crcm-marseille.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9bac40359a047dfd71cc05baef7c1bb9cd40093de92cc1527c35a1a818c1a3fd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9bac40359a047dfd71cc05baef7c1bb9cd40093de92cc1527c35a1a818c1a3fd?s=96&d=mm&r=g","caption":"Delphine"},"url":"https:\/\/crcm-marseille.fr\/en\/author\/contactbioself-communication-com\/"}]}},"_links":{"self":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts\/11874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/comments?post=11874"}],"version-history":[{"count":10,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts\/11874\/revisions"}],"predecessor-version":[{"id":12011,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/posts\/11874\/revisions\/12011"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/media\/11836"}],"wp:attachment":[{"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/media?parent=11874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/categories?post=11874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crcm-marseille.fr\/en\/wp-json\/wp\/v2\/tags?post=11874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}